TR
T. Rowe Price Investment Management, Inc. cut its BCAX stake below 5%
T. Rowe Price Investment Management, Inc. reported owning 4.2% of Bicara Therapeutics Inc. (BCAX) (2,804,772 shares) in a Schedule 13G filed Oct 7, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 7, 2026
- Source
- Schedule 13G